Amsterdam, 21 July 2022 – Our portfolio company Mauritskliniek intends to join Corius. Mauritskliniek provides healthcare services in dermatology, varicose veins, proctology, skin therapy and medical-cosmetic care. The Mauritskliniek is located in Amsterdam, The Hague, Nijmegen, Utrecht and Veldhoven. Corius is the largest network of dermatology and phlebology practices in Germany and Switzerland.
By acquiring Mauritskliniek, Corius geographically expands its European healthcare offerings to the Netherlands. Both the services and vision of Mauritskliniek are perfectly consistent with those of Corius.
Mauritskliniek intends to join Corius in the third quarter of 2022, after potential approval of the Nederlandse Zorgautoriteit (NZa).
About Corius
Corius is a network of dermatology and phlebology practices. Doctors and partners of Corius deliver the highest level of quality and apply the most modern technology. An absolute passion for the job and patients is pivotal in the way of working. Corius offers their patients holistic and individual treatments, whereby in-house expert knowledge is shared across cross-clinics and colleagues. Employees follow additional education and trainings throughout. Corius has 32 practices and employs 139 doctors and 615 employees. About 450.000 patients are treated each year. www.corius.de
About Mauritskliniek
Mauritskliniek is a specialized clinic for dermatology, treatment for varicose veins and medical-cosmetic care. After the acquisition of Kliniek Veldhoven in 2020, the range of cosmetic-care has been further expanded. The clinics are known for high quality and a pleasant way of working. Their values are personal, clear and well organized. The clinics offer both insured and uninsured care. Customer satisfaction is rated with 8.6/10 points, according zorgkaartnederland.nl. www.maurtiskliniek.nl
About Holland Capital
Over the past 40 years, Holland Capital has responsibly and successfully invested in over more than 150 SME-companies. With a clear investment strategy Holland Capital is active in the attractive growth markets of Healthcare and Technology. Holland Capital’s experienced and committed investment team aims to establish an open, sustainable, and professional relationship with the companies they invest in, with the common goal of achieving growth. Holland Capital is backed by a broad network of successful healthcare entrepreneurs in the relevant growth markets.
WSO2 Recognizes Integration Specialist Yenlo with Partner of the Year Award 2019
WSO2 Recognizes Integration Specialist Yenlo with Partner of the Year Award 2019 Based on its success in delivering open source integration and API management solutions in 2019, Yenlo has earned WSO2’s top partner award for the second year in a row and Most Certified...
Yenlo and 42Crunch Enter Strategic Partnership to Secure APIs and Enforce API Policies
Yenlo and 42Crunch Enter Strategic Partnership to Secure APIs and Enforce API Policies Yenlo will extend the value it brings to API customers worldwide by adding 42Crunch API security services to its existing service portfolio, including Connext, Yenlo’s WSO2-based...
Next step in growth ambitions: Valori appoints Jaap Merkus as CEO
Next step in growth ambitions: Valori appoints Jaap Merkus as CEO Utrecht, 11th of November 2019 – Software Testing and Quality Assurance Specialist Valori announces that Jaap Merkus will be appointed Chief Executive Officer (CEO) effective December 1, 2019. With the...
Yenlo Completes Advisory Board with the Addition of Sjoerd Blüm as a Third Strategic Member
Yenlo Completes Advisory Board with the Addition of Sjoerd Blüm as a Third Strategic Member Advisory board will enable global system integrator and API management specialist Yenlo to leverage the business insights of leading industry and financial executives in...
Defibrion attracts investor to execute its buy-and-build strategy
Defibrion attracts investor to execute its buy-and-build strategy Amsterdam, September 24th 2019 - Investment company Holland Capital invests in Defibrion, a fast-growing supplier of AEDs and other products and services related to in-house emergency services. With...
Avinty and Karify join forces to improve healthcare
Avinty and Karify join forces to improve healthcare Amsterdam, September 10th 2019 – Earlier this week, the shareholders of eHealth platform Karify came to an agreement around selling their shares to Avinty, a developer of software applications for healthcare...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 311 94 11
Düsseldorf
Inselstraße 34
40479 Düsseldorf
+49 (0) 211 43 63 69 01